MCL1 and prostate carcinoma: EA is also known to suppress the growth of prostate cancer cells and trigger the apoptosis of castration-resistant prostate cancer cells by attenuating the JAK2/STAT3/MCL-1 and NF-κB signaling pathways (Bao et al., 2021).